Research Studies Currently Recruiting

Cadence

Cadence is an observational registry designed to collect data on participants with cold agglutinin disease (CAD) or cold agglutinin syndrome (CAS).  The primary goal is to better understand patient and clinical characteristics, complications, long-term clinical and patient-reported outcomes associated with the different CAD and CAS treatments and health-resource utilization.  More information can be found here: https://clinicaltrials.gov/study/NCT05791708?term=NCT05791708&rank=1

CodeBreaK

CodeBreaK 202 is a interventional study for patients with non-small cell lung cancers with Stage IV or Advanced Stage IIIB/C disease.  The primary goal is to compare the survival rate after treatment with either Sotorasib Platinum Doublet Combination or Pembrolizumab Platinum Doublet Therapy.  More information can be found here: https://clinicaltrials.gov/study/NCT05920356?term=NCT05920356&rank=1

Cold Agglutinin Disease:
“Cold Agglutinin Disease Real World Evidence Registry (Cadence)”
https://clinicaltrials.gov/study/NCT05791708?term=cadence&cond=cold%20agglutinin&rank=1